Royalty Pharma plc Class A share price logo

Royalty Pharma plc Class A

NASDAQ: RPRX

Large Cap

$57.23

-0.52

(-0.90%)

as on

Royalty Pharma plc Class A Stock Performance

as on August 7, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $56.83
    $59.19
    downward going graph

    0.70%

    Downside

    3.42%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $34.08
    $60.44
    downward going graph

    40.45%

    Downside

    5.61%

    Upside

    downward going graph

Royalty Pharma plc Class A share price movements today

Previous Close
$57.75
Open
$58.94
Volume
1.6M
Day's Low - High
$56.83 - $59.19
52 Week Low - High
$34.08 - $60.44

Royalty Pharma plc Class A Historical Returns

1 Month Return
-0.09 %
3 Month Return
+ 15.04 %
1 Year Return
+ 56.04 %
3 Year Return
+ 87.38 %
5 Year Return
+ 56.12 %

Royalty Pharma plc Class A Stock Fundamentals & Key Indicators

Check Royalty Pharma plc Class A market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$33.1B

EPS (TTM)

5.2277

Dividend Yield

1.57%

Quarterly Earnings Growth YOY

0.23%

PE Ratio (TTM)

30.25

Industry PE ratio

3.7915384615384613

PEG Ratio

2.185

EBITDA

1.6B

Revenue (TTM)

2.4B

Profit Margin

33.86%

Return On Equity TTM

13.77%

Royalty Pharma plc Class A Stock Valuation

Track how Royalty Pharma plc Class A P/E has moved over time to understand its valuation trends.

Royalty Pharma plc Class A in the last 5 years

  • Overview

  • Trends

Lowest (5.79x)

December 31, 2023

Industry (3.79x)

August 7, 2026

Today (30.25x)

August 7, 2026

Highest (14.63x)

September 30, 2022

LowHigh

Today’s Price to Earnings Ratio: 30.25x

Royalty Pharma plc Class A vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Royalty Pharma plc Class A with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$33.1B56.12%30.2533.86%1.5699999999999998%
BUY$41.1B605.15%NA0.00%NA
BUY$121.3B141.61%27.9335.00%NA
BUY$78.3B25.82%18.827.87%0.48%

Stock Returns calculator for Royalty Pharma plc Class A Stock including INR - Dollar returns

The Royalty Pharma plc Class A stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Royalty Pharma plc Class A investment value today

Current value as on today

₹1,67,810

Returns

₹67,810

(+67.81%)

Returns from Royalty Pharma plc Class A Stock

₹54,634 (+54.63%)

Dollar Impact

₹13,176 (+13.18%)

Analyst Recommendation on Royalty Pharma plc Class A Stock

Based on 14 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 14 analysts, 85.71% of analysts recommend a 'BUY' rating for Royalty Pharma plc Class A. Average target price of $61.62

Royalty Pharma plc Class A Share Price Target

Get share price movements and forecasts by analysts on Royalty Pharma plc Class A.

What analysts predicted

7.12%UPSIDE

Target Price

$61.62

Current Price

$57.23

Analyzed by

14 Analysts

Target

$61.62

Royalty Pharma plc Class A target price $61.62, a slight upside of 7.12% compared to current price of $57.23. According to 14 analysts rating.

Indian Investors' Interest in Royalty Pharma plc Class A Stock

Search interest for Royalty Pharma plc Class A Stock has increased by 67% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:67% versus previous 30 day period

Royalty Pharma plc Class A Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
567
537
564
593
568
578
609
621
630
674
Gross Profit
567
537
564
593
568
578
609
621
629
405
Operating Income
-73
269
735
361
534
209
427
388
632
133
EBITDA
39
243
872
400
498
159
525
451
563
175
Interest Expense
44
49
66
65
65
68
79
94
93
93
Depreciation
-
-
-
-
-
1
1
1
1
-
Income Before Tax
-4
194
806
334
433
90
444
355
468
81
Income Tax Expense
-9
92
262
126
-
60
155
142
173
-
Net Income
4
102
543
208
238
30
288
214
295
17
Net Profit Margin
0.84%
18.99%
96.33%
35.07%
41.94%
5.21%
47.30%
34.44%
46.78%
2.65%

Royalty Pharma plc Class A Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1,877
1,597
1,794
1,814
2,122
2,289
2,237
2,354
2,263
2,378
Gross Profit
1,877
1,597
1,794
1,814
2,122
2,289
2,237
2,354
2,263
2,378
Operating Income
722
939
1,364
2,623
1,595
1,430
307
1,492
1,292
1,559
EBITDA
1,069
1,623
1,831
2,753
1,882
1,430
423
1,887
1,556
1,635
Interest Expense
238
247
279
268
157
166
187
187
225
307
Depreciation
-
33
33
23
23
22
5
-
-
3
Income Before Tax
761
1,343
1,517
2,461
1,701
1,241
230
1,700
1,330
1,324
Income Tax Expense
195
542
433
349
1,147
762
187
565
472
553
Net Income
565
1,210
1,377
2,348
975
619
42
1,134
858
770
Net Profit Margin
30.14%
75.72%
76.76%
129.45%
45.94%
27.07%
1.91%
48.20%
37.95%
32.42%

Royalty Pharma plc Class A Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
194
806
334
433
90
444
355
294
18
Operating Cash Flow
658
703
742
596
363
702
827
760
728
Investing Cash Flow
-893
-1,192
-505
503
-311
-958
-847
-520
-230
Financing Cash Flow
1,156
-325
-257
-941
-507
562
-299
-272
-273
Change in Cash
921
-814
-21
158
-455
307
-320
-32
226

Royalty Pharma plc Class A Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
1,343
1,517
2,461
1,701
1,241
230
1,700
1,330
1,324
Operating Cash Flow
1,418
1,618
1,667
2,034
2,017
2,143
2,987
2,768
2,489
Investing Cash Flow
-1,587
303
-2,153
-2,759
-1,870
-1,029
-2,072
-2,678
-1,614
Financing Cash Flow
-123
-1,379
-1,191
1,487
385
-944
-2,148
361
-1,185
Change in Cash
-292
542
-1,640
763
532
169
-1,233
452
-310

Global Institutional Holdings in Royalty Pharma plc Class A

Funds
Holdings
Swedbank AB
2.42%
Vanguard Capital Management, LLC
1.02%
Jane Street Group LLC
1.11%
Bank of America Corp
0.79%
State Street Corp
2.48%

Royalty Pharma plc Class A News & Key Events

  • img

    Today's Timeline - 06 May

    Wed, 06:45 PM

    -

    Royalty Pharma reports strong earnings, beats EPS and revenue estimates, and maintains a Zacks Rank of #2 (Buy).

Insights on Royalty Pharma plc Class A

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 6 quarters, 568.24M → 674.14M (in $), with an average increase of 3.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 532.2% return, outperforming this stock by 443.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 438.0% return, outperforming this stock by 382.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, RPRX stock has moved down by -2.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 294.99M → 17.88M (in $), with an average decrease of 93.9% per quarter

About Royalty Pharma plc Class A

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.
OrganisationRoyalty Pharma plc Class A
Headquarters110 East 59th Street, New York, NY, United States, 10022
IndustryBiotechnology
CEOMr. Pablo Legorreta
E-voting on sharesClick here to vote

Key Management of Royalty Pharma plc Class A

Name

Title

Mr. Terrance P. Coyne

Executive VP & CFO

Mr. Christopher Hite

Chairman of Partnering & Investments

Mr. Greg Butz

Executive Vice President of Partnering & Investments

Mr. Eric Cornelius Schneider

Senior VP & Chief Technology Officer

Ms. Molly Sawaya

Executive VP & Head of Human Capital

Mr. Pablo Legorreta

Founder, Chairman of the Board & CEO

Dr. Marshall Jonathan Urist M.D., Ph.D.

Head of Research & Investments

Dr. James Folmar Reddoch Ph.D.

Executive VP of Investments & Chief Scientific Officer

Mr. George Grofik C.F.A., CPA

Senior VP and Head of Investor Relations & Communications

Mr. Arthur Richard McGivern J.D.

Executive VP of Investment & Chief Legal Officer

FAQs

What is Royalty Pharma plc Class A share price today?

Royalty Pharma plc Class A share price today is $57.23 as on at the close of the market. Royalty Pharma plc Class A share today touched a day high of $59.19 and a low of $56.83.

What is the 52 week high and 52 week low for Royalty Pharma plc Class A share?

Royalty Pharma plc Class A share touched a 52 week high of $60.44 on and a 52 week low of $34.08 on . Royalty Pharma plc Class A stock price today i.e. is closed at $57.23,which is 5.31% down from its 52 week high and 67.93% up from its 52 week low.

What is Royalty Pharma plc Class A's market capitalisation today?

Royalty Pharma plc Class A market capitalisation is $0.03T as on .

How to invest in Royalty Pharma plc Class A Stock (RPRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Royalty Pharma plc Class A on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Royalty Pharma plc Class A Shares that will get you 0.0262 shares as per Royalty Pharma plc Class A share price of $57.23 per share as on August 7, 2026 at 1:29 am IST.

What is the minimum amount required to buy Royalty Pharma plc Class A Stock (RPRX) from India?

Indian investors can start investing in Royalty Pharma plc Class A (RPRX) shares with as little as ₹95.2 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.00 in Royalty Pharma plc Class A stock (as per the Rupee-Dollar exchange rate as on ). Based on Royalty Pharma plc Class A share’s latest price of $57.23 as on August 7, 2026 at 1:29 am IST, you will get 0.1747 shares of Royalty Pharma plc Class A. Learn more about fractional shares .

What are the returns that Royalty Pharma plc Class A has given to Indian investors in the last 5 years?

Royalty Pharma plc Class A stock has given 56.12% share price returns and 28.42% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?